Adam Roseman Online

ARC Investment Partners, LLC is a private equity firm that invests primarily in companies in China. Adam Roseman, ARC China Founder and Chief Executive Officer, strongly believes that the country holds a significant amount of potential, which most firms have yet to acknowledge.

ARC is supported both financially and strategically by its investors.  Roseman has stated that: “Maintaining strategic partnerships with prominent investment banking firms and other service providers is critical to the long-term success of our portfolio companies. Our ability to execute successful investments is based on our strategic partnership with major investment banking, auditing, recruitment and legal firms, and is supported by our commitment on ongoing investor relations support, as well as substantial portfolio company business development and operational support.”

Last April, the Guild of Big Brothers Big Sisters launched its annual luncheon in support of Big Brothers Big Sisters of Greater Los Angeles and the Inland Empire, with trustee Adam Roseman. The event took place at the Beverly Hills Hotel, and featured highly fashionable clothes, accessories and more from the well-known, chic store Neiman Marcus.

Before the luncheon, a boutique sale presented the wares of numerous retailers, spas, salons and jewelers; all of which were donated and sold for the Big Brothers Big Sisters cause.

ARC ARC Investment Partners was mentioned in an article which appeared in the Economist, the prestigious business news journal headquartered in England. The article, entitled, “Global Private-Equity Firms are Seduced by the China Dream,” The private equity firm ARC Investment Partners is described in the following way: “ARC China is another small firm with experienced managers (that) invests only in companies which collect revenues in an obviously verifiable way, such as a retail company that receives fees from franchisees at a single point, rather than from a string of wholly owned stores.”

Among those “experienced managers” is Adam Roseman, the managing director and founder.

ARC China, with CEO Adam Roseman, has announced that Joshua Kurtzig will be joining their team as a Managing Director. As head of ARC China’s Beijing office, Kurtzig will be in charge of business development, execution and portfolio management.

Before joining ARC China, Kurtzig was a director of DAC Management, where he ran the firm’s finance and distressed equity group. He was also the Director of Financial Advisory Services at Stonebridge International, where he was responsible for market entry strategies as well as for providing investment advice.

The Healthy Habits for Kids workshops are part of Cedars-Sinai Medical Center’s efforts to prevent obesity. This ten-week program is offered in schools in the Los Angeles area, and focuses on encouraging children to eat well and exercise regularly by instilling these habits at a young age. The program believes that healthy habits begin through curiosity, and therefore the health educators make sure to include the children, answer questions and pique their interest.

Cedars-Sinai Medical Center, where Adam Roseman is a member of the board, is an organization which works to provide high quality healthcare and state-of-the-art medical research.

Nine years ago, Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute discovered a small change which occurs in the molecular structure of the most violent type of brain tumor; the glioblastoma multiforme. When they dug deeper, they detected that a specific protein called laminin- 411 supports the building of the tumor’s new blood vessels, which enable its widespread growth. At the time, there was no technology available that could block this protein.

Recently, a research team from Cedars-Sinai, which is a non-profit organization where Adam Roseman is a board member, has created a drug which is injected into the bloodstream and carried to the tumor. The drug is triggered by the different pH level in the cancerous cells, and blocks the tumor cells’ production of the harmful laminin-411 protein. This new method is regarded as the first of its kind.

A new surgical imaging device was recently developed and tested in Cedars- Sinai Medical Center, where Adam Roseman is a member of the board of governors. The new scope, called a VITOM, was studied by Neurosurgeon Adam N. Mamelak M.D. , who is practiced in minimally invasive pituitary surgery and is co-director of the Pituitary Center at Cedars-Sinai. During his inspection of the device, Dr. Mamelak was asked by veterinary endocrinologists and surgeons from VCA West Los Angeles Animal Hospital if it could be used in similar operations for animals. Some pituitary tumors are very common in dogs, and are often fatal.

After further examining the scope, Mamelak found that it could indeed be used for animal neurosurgery as well. He agreed to teach the veterinary surgeons how to use it while performing life-saving operations to remove the tumors. The surgery benefits both humans and dogs in an additional way; the removed tumors are sent back to the Cedars-Sinai labs for further examination and testing, with hopes of discovering a drug that can be used as a non-invasive cure.

There is currently only one other organization, located in the Netherlands, working to surgically remove pituitary tumors in canines. Both groups use a transsphenoidal approach, which is basically creating a small hole at the back of the mouth in order to enter the skull at the base of the brain. This has been only partially effective in veterinary surgery until now, because dogs have long snouts which make it harder for the surgeons to see what they are doing. The VITCOM is a wonderful solution to this problem, as it magnifies the operation field by up to 12 times.

Adam Roseman, Founder and Managing Director of ARC China, announced on September 20, 2010 that he would be moderating a panel discussion.  The panel discussion, titled “Examining the Development & Growth of a Sustainable Domestic Private Equity & Venture Capital Ecosystem In China: What More Is Needed For The Long Term Strength Of The Industry?” was part of the China Summit at SuperReturn Asia 2010.

SuperReturn Asia 2010 is the region’s main annual Private Equity and Venture Capital Industry event, and it was co-sponsored this year by Adam Roseman’s investment firm, ARC China.  This year’s conference was held from September 27-30 at the JW Marriot Hotel in Hong Kong.

The panel examined a number of current topics including exit strategies and the need for transparency in China’s domestic listing process.

SuperReturn Asia is the premier  conference, held annually, which examines the Private Equity and Venture Capital Industry in China and Asia. This year’s conference took place on September 27-30, 2010 and was co-sponsored by the investment firm ARC China. Adam Roseman, the founder and managing Director of ARC China, was the moderator for an informative panel discussion investigating a particular aspect of the private equity and venture capital industry entitled, “Examining The Development & Growth Of A Sustainable Domestic Private Equity & Venture Capital Ecosystem In China: What More Is Needed For The Long Term Strength Of The Industry?”

This panel discussion was part of the popular “China Summit,” one of the  events at the SuperReturn Asia 2010 conference. The panel looked at many relevant subjects that are of interest, including exit strategies and the importance and need for transparency in the domestic listing process in China. Also discussed were ways to expand mainstream securities and other financial structures, the growth and change of the legal and educational institutions which are critical for the support of China’s growing private equity industry, and other crucial subjects.

The end of September, 2010 saw Adam Roseman once again involved in an informative panel discussion entitled “Examining The Development & Growth Of A Sustainable Domestic Private Equity & Venture Capital Ecosystem In China: What More Is Needed For The Long Term Strength Of The Industry?” The panel discussion, which was moderated by Roseman, founder and managing director of ARC China, took place during the China Summit at SuperReturn Asia 2010, which was held from September 27-30.

SuperReturn Asia is the flagship conference held annually which takes an in-depth look at the past, present and future of the private equity and venture capital industry in China and the rest of Asia.  ARC China, Adam Roseman’s firm, was a co-sponsor of this influential and well-attended conference.